Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tricalcium phosphate is a calcium salt of phosphoric acid with the chemical formula Ca3(PO4)2, primarily used as a dietary mineral supplement to treat or prevent calcium deficiencies. It serves as a source of both calcium and phosphate ions, which are essential minerals for bone formation, nerve transmission, and muscle function. Clinically, it is indicated for conditions such as osteoporosis, hypocalcemia, hypoparathyroidism, and osteomalacia. Beyond its therapeutic use, tricalcium phosphate is widely employed as a pharmaceutical excipient (glidant or diluent), a food additive (anticaking agent), and a biocompatible material in orthopedic and dental applications as a bone graft substitute due to its osteoconductive properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tricalcium phosphate.